
Meltolan RD 20mg Tablet
Marketer
Alkem Laboratories Ltd
Salt Composition
Olanzapine (20mg)
Overview Meltolan RD 20mg Tablet
Rilmelia 20mg tablets treat schizophrenia (a mental illness causing hallucinations, delusions, impaired thought, and behavior) and mania. Rilmelia 20mg can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Discontinuing this medication abruptly is unsafe and may exacerbate symptoms; consult your physician before stopping treatment. Common side effects include dry mouth, constipation, muscle stiffness, and agitation. Initial use may cause orthostatic hypotension (sudden blood pressure drops upon standing); rise slowly from sitting or lying positions. Dizziness and drowsiness are also possible; avoid driving or mentally demanding tasks until the drug's effects are known. Weight gain, elevated blood sugar, and increased cholesterol are potential side effects, mitigable through healthy eating and regular exercise. Rare but serious adverse reactions such as hyperglycemia (extremely high blood sugar) and convulsions may occur.
Primary Ingredients of Meltolan RD 20mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Meltolan RD 20mg Tablet
Managing Manic Episodes | Addressing Schizophrenia
Major Benefits of Meltolan RD 20mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Meltolan RD 20mg Tablet can be administered with or without food, although consistent timing is recommended.
Common Side effects of Meltolan RD 20mg Tablet:
- Dizziness
- Sleepiness
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Dryness in mouth
- Weight gain
- Increased prolactin level in blood
- Constipation
- Muscle stiffness
- Restlessness
- Tremors
How to use Meltolan RD 20mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 20mg Meltolan RD Tablet whole; avoid chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
How Meltolan RD 20mg Tablet works:
A single 20mg Meltolan RD tablet, an atypical antipsychotic medication, modifies dopamine and serotonin neurotransmitter levels to positively impact mood, cognition, and conduct.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Meltolan RD 20mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Meltolan RD 20mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Administering Meltolan RD 20mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Meltolan RD 20mg tablet might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Meltolan RD 20mg tablets can be safely administered to patients with renal impairment without requiring any modification to the prescribed dosage.
LiverSAFE IF PRESCRIBED
The use of Meltolan RD 20mg tablets in patients with liver disease is likely safe. Available evidence indicates dose modification may not be necessary, but a physician's consultation is recommended.
What if you forget to take Meltolan RD 20mg Tablet :
Should you forget a dose of Meltolan RD 20mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Meltolan RD 20mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Thienobenzodiazepine analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
